156 related articles for article (PubMed ID: 17974279)
41. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis of gastric cancer by serum proteomic fingerprinting.
Poon TC; Sung JJ; Chow SM; Ng EK; Yu AC; Chu ES; Hui AM; Leung WK
Gastroenterology; 2006 May; 130(6):1858-64. PubMed ID: 16697748
[TBL] [Abstract][Full Text] [Related]
43. [The contribution for the diagnosis of the tumor-like polypoid lesions of the gallbladder by SELDI-TOF-MS].
Luan FM; Ge CL; Ma N; Li YZ; Hu CJ; Li N
Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(7):525-7. PubMed ID: 18785564
[TBL] [Abstract][Full Text] [Related]
44. Utility of serum peptidome patterns of esophageal squamous cell carcinoma patients for comprehensive treatment.
Wan QL; Hou XS; Zhao G
Asian Pac J Cancer Prev; 2013; 14(5):2919-23. PubMed ID: 23803054
[TBL] [Abstract][Full Text] [Related]
45. [Construction of protein fingerprint signature in serum and its significance for early diagnosis with chronic allograft nephropathy].
Zhou ST; Yan JH; Yang C; Zeng N; Wu K; Chen ZH
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1966-9. PubMed ID: 17064591
[TBL] [Abstract][Full Text] [Related]
46. [Clinical significance of serum proteomic profiling before and after cervical cancer surgery].
Shao ZY; Zheng ZG; Lou HM; Zhang P
Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):374-8. PubMed ID: 19573315
[TBL] [Abstract][Full Text] [Related]
47. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
48. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine].
Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811
[TBL] [Abstract][Full Text] [Related]
49. Serum markers as predictors of esophageal squamous dysplasia and early cancer.
Chen W; Abnet CC; Wei WQ; Roth MJ; Lu N; Taylor PR; Pan QJ; Luo XM; Dawsey SM; Qiao YL
Anticancer Res; 2004; 24(5B):3245-9. PubMed ID: 15510618
[TBL] [Abstract][Full Text] [Related]
50. Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK.
He H; Sun G; Ping F
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(5):208-13. PubMed ID: 19735007
[TBL] [Abstract][Full Text] [Related]
51. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
52. Serum protein profile analysis following definitive treatment in patients with head and neck squamous cell carcinoma.
Gourin CG; Moretz WH; Weinberger PM; Xia ZS; Liu Z; Terris DJ; Adam BL
Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1125-30. PubMed ID: 18025317
[TBL] [Abstract][Full Text] [Related]
53. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
[TBL] [Abstract][Full Text] [Related]
54. [Application of SELDI-TOF-MS technology in study of laryngeal carcinoma biomarkers].
Xu Y; Huangfu H; Wang B; Cheng Y; Zhang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Sep; 22(18):820-3. PubMed ID: 19166025
[TBL] [Abstract][Full Text] [Related]
55. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
[TBL] [Abstract][Full Text] [Related]
56. Possible prediction of chemoradiosensitivity of esophageal cancer by serum protein profiling.
Hayashida Y; Honda K; Osaka Y; Hara T; Umaki T; Tsuchida A; Aoki T; Hirohashi S; Yamada T
Clin Cancer Res; 2005 Nov; 11(22):8042-7. PubMed ID: 16299234
[TBL] [Abstract][Full Text] [Related]
57. Protein fingerprint of colorectal cancer, adenomatous polyps, and normal mucosa using ProteinChip analysis on laser capture microdissected cells.
Xu W; Chen Y; He W; Fu Z; Pan T; He H; Yu J; Wei Q; Zheng S; Zhang S
Discov Med; 2014 May; 17(95):223-31. PubMed ID: 24882714
[TBL] [Abstract][Full Text] [Related]
58. Using SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis.
Liu W; Li X; Ding F; Li Y
Scand J Rheumatol; 2008; 37(2):94-102. PubMed ID: 18415765
[TBL] [Abstract][Full Text] [Related]
59. An approach to the characterization of serum low-molecular weight proteins/peptides in liver injury using SELDI-TOF MS and factor analysis.
Liu X; Li L; Zhang G; Sheng G; Xu W
Clin Biochem; 2007 Nov; 40(16-17):1266-71. PubMed ID: 17706629
[TBL] [Abstract][Full Text] [Related]
60. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma.
Wang JX; Yu JK; Wang L; Liu QL; Zhang J; Zheng S
Proteomics; 2006 Oct; 6(19):5344-9. PubMed ID: 16941571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
